Venture Intelligence data shows that capital flowing into India's manufacturing startup sector climbed from $164 million in 2020 to $1.92 billion through 2026, reflecting a broader shift in where investors have chosen to direct their attention. Deal volume climbed from 31 transactions recorded in 2020 to 127 by 2026.
Companies like Pulse, a maker of medical equipment, and Scimplify, which manufactures specialty chemicals and operates an end-to-end supply chain platform, have been drawing stronger interest from buyers within the domestic market. One industry participant noted that the disruptions of Covid led businesses to recognise the practical value of building redundancy into their supply arrangements.
Abhishek Srivastava, managing partner at early-stage venture capital firm Kae Capital, noted that those shifts opened up appetite for diversified global supply chains, with India taking shape as a viable secondary sourcing option, while an expanding domestic market led businesses to recognise that substantial scale was attainable before any push into international markets became necessary. Among the manufacturing-focused positions Kae Capital has built into its portfolio, one of the earliest was a stake in Zetwerk, a business-to-business platform in that sector that is now moving toward a public listing.
Heightened friction over trade policy and the tariffs that followed have pushed companies and governments alike to spread their sourcing across multiple regions while building up production capacity closer to home. Levies placed on goods flowing in from China marked the opening move in a trade dispute between the two economies that took shape in 2018. When the White House rolled out a reciprocal-tariff policy in 2025 — one that covered a broad set of trading partners, India included — businesses found themselves rethinking their entire approach to global supply chains.
For much of the past, ventures built around physical assets drew limited attention from investors, in part because the frequency of failures meant that whatever a collapsed enterprise left behind tended to carry little recoverable value — and any intellectual property the business had accumulated along the way was routinely set aside when that calculation was made. Worth, in that account, flowed exclusively through the lens of capital.
IP-led manufacturing stands out as a defining characteristic of the approach under examination here. Proprietary intellectual property, an investor made clear, stands as a prerequisite before any funding commitment can be considered.
Vikas Choudhury, founder and managing partner of the growth-stage venture capital firm Playbook Partners, described the model as one that combines two distinct advantages within a single approach. Choudhury's analysis holds that when manufacturers anchor their operations in proprietary intellectual property, they raise two distinct obstacles — one rooted in capital, the other in technology — that competing firms typically require between one and two years to navigate around, assuming they manage it at all. Skyroot has reached unicorn valuation within the spacetech sector, placing it among the ventures that Playbook Partners has chosen to fund.
Two policy instruments — the production-linked incentive scheme and the electronics components manufacturing scheme — form part of a broader government effort to expand domestic manufacturing capacity. Introduced in 2020 to funnel incentives tied to output across 14 sectors — electronics, automobiles, and pharmaceuticals among them — the PLI scheme has generated investor appetite substantial enough, in the view of Sumeet Seraf, founder and managing partner of the investment banking platform Equity360, to lift his manufacturing deal flow from around three or four transactions each quarter to somewhere between eight and ten.
Demand from sectors spanning aerospace and defence, solar energy, semiconductors, batteries, and electric vehicles has been building for the advanced materials and specialty chemicals — among them rare-earth oxides and specialised metal compounds — that Bengaluru-based Scimplify develops and manufactures. Ministry of corporate affairs filings accessed via Tracxn put Scimplify's revenue at ₹204.3 crore in FY25, up from ₹18.3 crore the previous year — a rise of more than eleven times over. Its reported size has expanded eightfold since that point, according to the company's own figures.
Beyond geopolitical considerations, the startup points to a decade of technological advancement within India as a driver of the growing demand it has recorded. At Technology Readiness Levels 4 and 5, a number of these technologies had cleared laboratory testing but had not yet reached the threshold required for commercial deployment. A spokesperson noted that product categories within the advanced materials portfolio had expanded by a factor exceeding ten over the preceding six months, while certain technologies were now reaching TRL 9 — the threshold at which a system has demonstrated reliable operation under real-world conditions and stands ready for commercial deployment. Revenue, by the company's own account, came close to doubling across the preceding six months. Co-founder Sachin Santhosh projected that the organisation's output would roughly double from its present level within the following six months.
Founded nine months ago, Pulse supplies hospitals and clinics with low- to medium-complexity devices and their associated consumables across five treatment areas: critical care, renal care, cardiac care, aesthetics, and rehabilitation. The company partners with manufacturers and small and medium enterprises under contract manufacturing arrangements, while a research and development facility in Visakhapatnam drives its own product and design work — though a spokesperson noted that the share of business generated in the first two months remained modest by the company's own account.
The organisation's size expanded to roughly eight times its earlier scale in the period that followed. Month-on-month expansion of between 30 and 40 percent has been recorded across consecutive reporting periods. Anshul Sharma, co-founder of Pulse, projected that the company's annualised revenue run rate would reach approximately ₹100 crore within the following one to two months. A Series A fundraising round is being pursued by the company, with the proceeds earmarked for expanding research and development work and pushing operational growth forward.